Authenticity and trust need to be at the core of effective storytelling, especially for social media influencers promoting a product or service. Yet that trust between an influencer and their audience is often in question these days and they don’t always disclose brand partnerships in accordance with FTC endorsement guidelines.

That’s why we’re excited to see the FTC released new influencer-friendly resources focused on transparency.

New Influencer-Friendly Tools

The FTC published a series of new tools for influencers which include:

  1. New website landing page gov/influencers
  2. PDF guide: Disclosures 101 for Social Media Influencers
  3. A series of short videos you can download or watch on YouTube, including: Advice for Social Media Influencers

These tools give influencers straightforward instructions on how to be legally compliant when working with brand partners. It clearly defines when to disclose that you’ve worked with a brand, correct terminology to use and where to place the disclosure.

We’re impressed the guide is aimed at influencers rather than lawyers and marketers, as it’s written in plain language that social media influencers will be able to easily understand. According to their news release, the new tools summarize existing guidance, including the Endorsement Guides and a 2017 question-and-answer document.

Companies are Responsible, Too

While the FTC is targeting influencers with this new set of tools, we can expect they’ll continue to monitor the brands partnering with them. It should come as no surprise that companies are responsible for requiring influencers to disclose and ensure it’s happening properly. Yet, we still regularly hear stories from influencers who are asked NOT to disclose by the companies who are paying them to partner on content.

A Few Surprising Tips

Our clients rely on us to stay on top of FTC regulations for influencer partnerships and know them inside and out. Here are a few of the top tips we share with clients (and influencers they partner with) that are often unknown.

  1. Perks are compensation – The definition of a financial relationship between an influencer and a brand was previously a gray area. The guide helps clarify this, stating: “Financial relationships aren’t limited to money. Disclose the relationship if you got anything of value to mention a product.” This includes free products, discounts, travel arrangements, meals, gift cards or any other perks, even if an influencer is not under contract or required to post about it.
  2. Hashtags are not required – Despite what’s been ingrained in our minds over the years, you are not required to use hashtags on your “#ad” and “#sponsored” disclosures. You can use the words in a sentence in a more conversational and relatable way if you clearly identify the partnership. Reminder: “thanks” and “spon” are not adequate disclosure.
  3. Platform tools are not enough – Influencers need to use straightforward partnership language in the body of their posts, in addition to any disclosure tools the social platforms require, such as Facebook’s Branded Content Tool.
  4. Be conservative – It’s important to err on the side of caution, especially in regulated industries, such as healthcare and finance. For example, if you’re working with a patient influencer to promote a disease education campaign, require they disclose the company name on all posts in addition to disclosing that the content is sponsored. Not doing so can appear to veil the partnership and could cause a great backlash of mistrust among your target audiences.

Encourage Understanding and Compliance

We recommend socializing these new tools within your company, especially with social, legal and compliance teams. Consider proactively sending an email to influencers you work with to ensure they’ve seen the new tools and reinforce that you take endorsement laws seriously. We’ve already decided to include a link to the new Disclosures 101 for Social Media Influencers in influencer contracts.


Article contributed by Senior Group Director of Social and Influencer Engagement, Missy Voronyak and Hannah Byl, Associate, Influencer Engagement

Interested in learning more about W2O? Check out our About or Healthcare pages.

Read More

For those that haven’t heard about HLTH, a 6,000 person conference that promises to “Create Health’s Future,” it feels a little like if SXSW, ASCO and HIMSS decided to have a baby. The innovative event does a good job of mixing large, well-established companies like Optum, Aetna, CVS Health, Amazon, Walmart, Pfizer, Lyft and many more with hundreds of players from the digital health/startup ecosystem. HLTH also features numerous media outlets, government officials, academics and even celebrity billionaires like Mark Cuban.

What’s important about this two year old event founded by CEO and Chairman, Jonathan Weiner (he also founded well known global events, Money20/20 and Shoptalk) is that it combines companies that are well established players in health with those who are laying the foundation for a new future. For at least now, the event boasts a thousand CEOs (many are from the startup world), which obviously helps bringing a number of important players in the healthcare space to the event.

While I didn’t get to attend all the sessions, I was able to get enough of a taste of the content to see some key trends emerge.

1. Data is more critical to healthcare now than ever.

This may sound like the biggest “no duh” ever but what I found exciting is that a lot of the right people are starting to pay close attention to it. This includes the FDA, large pharma companies like Pfizer, Google (shocker), 23andMe, Walmart and numerous payer/providers.

Clearly the head of Google Health, David Feinberg, struck a chord with his quote about putting a search bar on top of electronic health records (my tweet capturing his sentiment garnered 17 retweets and 60 likes as of this writing). One of the bigger surprises to me was Principal Deputy Commissioner of the FDA, Amy Abernethy, announcing that the FDA would soon be ingesting data via an API versus PDF forms during a fireside chat with healthcare reporter, Chrissy Farr of CNBC. This is a far cry better than faxes that were once the medium of choice but hard to believe that the government is just getting to this point now in 2019.

2. Healthcare outsiders have an opportunity to fix healthcare.

Mark Cuban, owner of the Dallas Mavericks (NBA) and celebrity judge on the television show, Shark Tank, has put together a plan on how to fix healthcare. During a highly entertaining, expletive-filled conversation with former head of Medicare, Medicaid and the ACA under Obama, Andy Slavitt, Cuban exclaimed, “Right now, healthcare is so politically charged that people aren’t trying to solve problems. They’re not even trying to identify problems. They’re trying to sell what’s most politically expedient for them.” I suggest reading FierceHealthcare’s full writeup of the session here. What struck me most about this conversation is that when people like Cuban, Bill and Melinda Gates and Mark Zuckerberg/Priscilla Chan take on a cause, things get done. I don’t know as though Cuban will solve our healthcare issues anytime soon but he’s not afraid to look at bold approaches.

3. Voice technology is going to big in health.

During one of the sessions featuring Rasu Shrestha, Chief Strategy Officer of Atrium Health, Missy Krasner, Strategic Head of Partnerships, Alexa Health & Wellness at Amazon, and Jennifer Schneider, President of Livongo, spoke about how healthcare companies are starting to create HIPAA compliant “Skills” which are like apps for Amazon’s voice controlled device, Alexa. Even though this technology is still in its infancy stage, allowing older patients to re-order prescriptions, call a Lyft/Uber to take them to an appointment, remind them to take their pills/test blood sugar levels, eat healthier, etc. will be a game changer over time. The healthcare companies that figure out how to meaningfully play in this space will be winners in the long run.

4. There are A LOT of digital health startups.

Walking through the expo floor, there were literally hundreds of companies there looking to make an impression. They ran the full gamut of wellness, AI, virtual reality, data, chatbots, etc. Sadly, many will not survive to see HLTH 2020 but this is a hot space so if you are an entrepreneur, this is a great time to focus on health.

Bringing this point home, 23andMe CEO, Anne Wojcicki, astutely noted during her featured session that “scale is critical” when it comes to the digital health space. She noted that over the last 11 years, 23andMe had amassed over 10 million customers with over 80% opting into their research panel.

5. Retailers want to bring health closer to the patient.

Head of health and wellness transformation at Walmart, Marcus Osborne, did a virtual walk through of one of their new clinics in Georgia showing all of the services customers could access. Given that Walmart is putting many of their clinics in Superstores which stay open 24/7, access to affordable healthcare is about to get a lot closer and easier. Other companies like CVS Health, Walgreens and even BestBuy are taking similar approaches to offering healthcare in store or in the latter case, creating a “Geek Squad” like offering where they could deliver services right to a patient’s doorstep.

There are at least a dozen other key themes I’ve missed in this recap but these were some of the most critical observations from the conference. To see more of the action, check out the HLTH2019 hashtag (I am proud to admit that I made it into the top 75 Twitter contributors at the event according to Symplur).

If you work in healthcare, my advice is to plan to attend HTLH 2020. It’s a great event and is only going to get better.

Interested in learning more about W2O? Check out our About or Healthcare pages.

Read More

In recent years, my mantra was “social media is free like a puppy is free” to convey the resources required to do social media right. This was to cover the basics: content strategy, paid promotion, community management and measurement. I’ve spent the past 10 years of my career focused on biopharma social media and I can assure you that, in 2019, the basics are no longer enough – we need to take advantage of the power of social media to have authentic conversations with our stakeholders. Social media is where audiences are spending a significant amount of time and offers a great medium to tell stories.

In this year’s Gallup survey on industry reputation, pharmaceutical companies sank to the very bottom with only 9% of Americans holding a “very positive” view of the industry, and 18% having a “somewhat positive” view. One way to help reverse that trend is to start using social media to humanize pharma and take control of the conversation.

True, authentic interaction on social media takes the following:

1. Preparation

Companies need systems in place to monitor the conversation and be able to nimbly respond. The best example of this was Sanofi’s response to Roseanne Barr’s assertion that its medication for insomnia was the reason she posted a racist tweet. There were two critical pieces to the success of Sanofi’s post: 1) the speed at which the company responded and 2) the relatable tone. (Please note that I was not involved in this response.) Sanofi clearly had a process in place to get the right decisionmakers quickly aligned on a plan of action. As demonstrated by this example, a detailed monitoring, engagement and issues protocol is essential to do social media well.

2. Resources
Analytics, including the use of AI and machine learning, can help us automate pulling the data, but we still need to layer on human intelligence for social media engagement. It’s basic customer service to respond to questions via social media even when the question or comment is critical. However, it’s important to keep in mind that social media isn’t necessarily the place to be having nuanced conversations about a personal medical condition. Those conversations should be taken offline in many cases.

3. Guts

Taking a stand and having a perspective can be risky. However, as recent current events around gun control have shown, consumers increasingly want to know where companies stand on issues. Millennials, in particular, care about purpose-driven brands. Earlier this year, PureTech Health’s CEO Daphne Zohar responded to Senator Elizabeth Warren’s criticism of the pharma industry, reminding her that pharma companies are made up of people. Zohar received significant engagement from stakeholders on Twitter. The majority agreed with Zohar’s point and did not agree with Senator Warren’s generalization of the industry. Biopharma companies need to stand behind their products and practices.

4. Expectation Setting

Understand that there will be trolls (dedicated to disparaging others) and detractors. It’s important to evaluate the influence of the person commenting, and the number of followers doesn’t always give the full picture. We like to say to our clients, “Don’t feed the trolls or let them distract you but monitor them.” People looking for a constructive conversation should be engaged and know that they are being heard. We use data and experience to address these sometimes complex situations. While we aren’t going to please everyone, it’s important to get our perspective into the conversation.

5. Empowered Employees

It’s easy for people to “hate” big pharma companies, but it’s harder to hate a person. Especially if that person is your neighbor who is on LinkedIn sharing the positive impact her pharma company is having in your local community. Biopharma CEOs have started to utilize social media, and our analytics show that they typically receive neutral to positive comments. It’s during times of business challenges that consumers and investors are quick to share their frustrations. While it’s great to see members of the C-site use social media, most, if they engage at all, are responding to media, policy and public figures and not to the average person.

However, it’s not only the C-suite who should be using social media to share the life-changing work of biopharma companies. Most companies have clearly defined social media policies that empower their employees to share on social media (excluding brand mentions). We have started to see employees in various roles up-level their social media channels in order to interact with stakeholders, including patient and physician influencers. Many are starting to use social media to build authentic relationships around a shared interest in healthcare and elevate the science.

In conclusion, relevant, authentic engagement can be done! We have been able to collaborate with forward-thinking biopharma clients and create processes using guardrails to do nearly real-time, unique engagement. While social media isn’t easy, it can positively impact a company’s business. However, it’s simply not enough to push out content on social media. We must be willing to engage in real conversation.

This article first ran in the October issue of O’Dwyer’s.

Read More

Meeting patients where they are, through actionable and personalized healthcare experiences, is essential for both them and their caregivers.

This week’s What2Know guest, Carina Edwards, CEO of Quil Health, dives into this, the power of tech within health, and her secret life as an introvert on today’s episode. Take a listen below.

Don’t miss an episode of What2Know, subscribe to our podcast on iTunesStitcher or Spotify!

If you’re interested in learning about W2O, check out our About and Healthcare page

Read More

*A Swiss Chat

As the ‘first W2O employee on the ground’ in our Zurich office, it is my pleasure to bring you up to speed with recent developments here.

The workplace opened this year, so it was important that we made our mark on the city.

To this end, in September 2019, we held our inaugural W2O EMEA Marketing Science Summit, which successfully brought together 40 of the brightest minds across science, marketing, and communications to discuss using data to market products and ideas.

My Journey to Zurich

But first, let me tell you about the route that brought me back to my country of origin. I was born in Geneva and educated in different European countries. An internship with the World Health Organization (WHO) nurtured my interest in healthcare. I started at W2O in New York then did a short-term rotation in London. Both were stepping stones to my return to Switzerland and specifically the amazing city of fondue and Toblerone – ZURICH!

With Switzerland as the global hub for many international pharma/biotech companies, it was important to establish a base close to our clients. The recruitment of Fenna Gloggner, a Senior Group Director in the Insights and Analytics practice, whose experience lies in Swiss pharma, will strengthen W2O’s links.

My Chat with Fenna Gloggner

What is your background?

Fenna: My academic background is in politics and economics, but my career has taken me firmly into the pharmaceutical world. I moved from my native Germany to the UK to attend university and became a trainee market researcher at GfK Health in London. After a few years learning the ropes, I made another move across the continent to Switzerland into a client-side role at Novartis in Basel.

At Novartis, I worked in various roles in global commercial insights, including primary market research, business analytics, forecasting, and competitive intelligence. A lot of my work was in cardiology and cardiovascular health, and I am still fascinated by the miracle that is the human heart.

After 10 great years at Novartis, I felt like a change of pace, so I moved to one of my former partner agencies, HRW, into a business development role. HRW is a pharmaceutical market research agency with some very innovative solutions in qualitative research and behavioural science, so the move also gave me an opportunity to refresh my primary market research skills. I also developed a passion for behavioural science and how it can enhance product or communication strategies.

It was about a year ago that I first heard about W2O when I got chatting to Laura Mucha (W2O Managing Director Analytics) after a conference. We stayed in touch, and with every conversation there seemed to be more points of connection, so I am excited to be joining the company now.

What are you hoping to bring to W2O and in particular the Swiss office?

Fenna: I’ve been very impressed by what I learned about W2O’s digital analytics offering – a lot of things that I wish I had had access to when I was working industry-side! I think there will be a real opportunity to complement this with my experience in primary insights. My work in the past has always been at a global level, so hopefully that will be a good fit, especially for the EMEA team.

Another thing I will be able to bring to W2O is my industry experience. In addition to working client-side for the majority of my career, I recently completed an MBA in Pharma Business Administration. Studying part-time alongside a full-time agency job was an intense but very rewarding experience. I learned a lot and was able to connect a lot of dots – the programme covered everything from strategic management, finance, and pharma law to development, marketing and markets access and pharmacovigilance. A lot of things that were always a bit vague to me in terms of how the various pharma functions connect – especially outside of the commercial setting – are a lot clearer to me now. I look forward to sharing what I know and learned with anyone who doesn’t yet feel fully up to speed with what is going on inside pharma.

Finally, it will be great to have a real presence on the ground for our Swiss clients: With the office in Zurich and me working from Basel for part of the week, we will be able to have a lot of meetings face to face instead of remotely, which obviously helps with building strong relationships. For most of the local Basel clients, I can be at their offices in under 30 minutes – something that they (and I) have certainly made use of in the past…

Nina: What is your connection to Switzerland?

Fenna: A very personal one: My husband and children are Swiss, and I am a proud naturalised Swiss citizen. I have a large and wonderful Swiss extended family and we like to spend time out in nature: hiking in summer; skiing in winter. Switzerland is a beautiful country and offers a great quality of life – I still feel privileged to be able live here and hope many of our colleagues will come to Zurich to work with us and experience Switzerland for themselves.

We’re looking forward to developing our Swiss office and continuing to host the annual summit in Switzerland.

Merci vilmal (thanks a lot) for reading my blog!

Read More

As electronic health record (EHR) systems became widespread, leading integrated delivery networks (IDNs) and hospitals began using the systems not just for internal records, but also to facilitate patient engagement. And so began the creation of created portals that allowed patients to make appointments, access after-visit summaries, view test results and pay bills. These portals were the first big step into digital patient engagement. But it’s time to move beyond them.

So where will hospitals and IDNs need to go next to  engage in an era where  consumers will push to have personalized services anywhere, anytime, in many areas of life? Here are five things to consider:

  1. Mobile Convenience: With two-thirds of people willing to use a mobile app to manage health-related issues, the question for IDNs is no longer whether to go mobile; it’s how. Will they send mobile reminders to do at-home physical therapy, schedule a screening or begin a pre-op routine? Will patients want to leverage connected devices to monitor symptoms, vital signs or behaviors? Will it be sending a detailed request around episodes of care that they have experienced? What about letting people video chat with a nurse on demand?

2. Personalization: For mobile experiences to be effective, they must be personalized – and the first step toward personalization is having the right data. IDNs need data to understand what kind of engagement a person needs and will respond to and what channel is most effective for them. And to go beyond personalized medicine into personalized health care, they also will need data from beyond clinic or hospital walls. This might include patient-reported or -generated data, consumer data, data from other providers or demographic data. Collecting all these inputs – which requires collaboration and system interoperability – creates a more complete picture of a person’s health to help IDNs map an effective, personalized journey.

3. Care Continuity: IDNs with multiple facilities, specialties and services must create platforms to ensure seamless engagement, discharge planning, at-home progress and continuity of care, especially for patients with chronic diseases. One way to do this is to put the patient at the center of the experience and ask, “what will this patient need next?” All instructions and records are “owned” by the patient and travel with them, rather than each area having its own record that must be shared or sent to others across the network. This seismic shift in perspective requires significant technical work, but the payoff is a unified, digital patient experience.

4. Ongoing Engagement: As IDNs work to engage people holistically, not just for a finite, specific treatment, the digital tactics change. What used to be a month’s worth of weekly post-op reminder emails might become a week’s worth of daily text messages with post-op advice tailored to the patient based on any comorbidities, a telehealth or video follow up by a NP/PA to check on recovery, followed by weekly encouragement messages and then monthly videos related to long-term recovery from the procedure and periodic wellness calls.

5. Public Social Sharing: In our public sharing culture, IDNs have the opportunity to monitor the digital spaces where their patients share health experiences without infringing on HIPAA or privacy regulations. When people share about an experience with an IDN clinic or provider, the IDN can respond publicly or privately and can use the information to improve services or engagement in the future. With a patient’s permission, IDNs could also take the use of public social sharing to the next level, using online activity to trigger an engagement point. For example, if a patient has invited their care team to follow a CaringBridge page, a post about the patient feeling unusually lethargic one day might trigger a nurse to call the patient rather than waiting for the patient to make contact.

We have advanced technologies today that can help us expand patient engagement from a passive information exchange to a dynamic, personalized, always-on experience. Organizations will need to change processes, structures – and mindsets – to realize the potential in these opportunities.

Interested in learning more about W2O? Check out our About or Healthcare pages.

Read More

Next week we’re kicking off W2O Days at the University of Wisconsin–Madison (#UW2O)! Modeled after the success of our Syracuse University Social Commerce Days, this inaugural two-day event is focused on educating students about healthcare marketing and communications by connecting them with industry leaders. One of those leaders includes Amy Atwood, Head of Vaccine Communications at Takeda.

In the Q&A below, she unpacks her passion for healthcare communications, offers up career advice, and gives us a a preview of her keynote address for #UW2O. Check out her interview.

What fuels your passion around being a communications leader in the healthcare space?

Amy: Communicators are core in every field, but when you work in healthcare you can directly impact people’s lives. I’ve been a cancer patient and a caregiver so I’ve personally seen the importance of timely, clear, accurate information for all stakeholders. Through your relevant, truthful communications, you can help people take ownership of their own health. That’s what drives me – I feel like I am actually helping people.

What are the biggest changes you’ve seen in the field of communications over the last 20+ years?

Amy: Oh so many changes! Most are due to the rapid changes in technology: we can bring our laptops home, we no longer carry beepers, we don’t have to read 10 newspapers every morning, cut out the relevant articles and paste them together to make a book of daily media coverage – and then fax it to the various offices! We also have our smart phones that place the world at our fingertips – and that leads us to possibly the biggest change over the last 20+ years: social media. It simply didn’t exist when I started in Corporate Communications! No Twitter, Facebook, Instagram, Snapchat… The news cycle is now 24/7, instantaneous and every person has a voice. It’s much harder to own and shape your story.

You generously agreed to come and speak to some of the students at the University of Wisconsin-Madison. Tell us a little bit about your keynote?

Amy: I love to hear other people’s stories and learn from them, so I will share my career journey in hopes it will spark some ideas and provide inspiration for their future. My career has been filled with many ups, downs and zig zags along the way, but what has remained consistent is always doing what I love and looking for the silver lining, even when there doesn’t appear to be one.

What inspired you to want to spend time with these amazing students?

Amy: When I was in school, I had barely heard about Corporate Communications. I want to bring it to life for them, share the realities and give them encouragement as they embark on their careers. They are our future colleagues!

What piece of advice would you give your 20-something self?

Amy: All your hard work will pay off. Keep working as hard as you can, being guided by your values and instincts, and don’t be afraid to speak up, especially to advocate for what you know is right.

Read More

Ready or not, here it comes. The transformative potential of data and marketing science has reached the healthcare industry and – according to what we learnt at our EMEA Marketing Science Summit in Zurich last Wednesday – we’d better shape up.

“Digital integration is the number one priority in healthcare,” came the resounding pronouncement from our keynote speaker, Dr Jamil El-Imad, Chief Scientist at It’s a sentiment that we certainly believe in.

So, in that light, what can take away from our 2019 Summit? Here are five key learnings.

  1. Connecting the Data Dots

Yes, data sources in the healthcare industry are siloed even within organizations, but that shouldn’t limit what you can achieve. Take these two innovative examples discussed at the event:

The trailblazing Swiss Brain Data Bank (SBDB) is accelerating scientific progress by enabling researchers to collaborate across digital databanks to improve diagnosis and treatment of brain disorders.

VirtaMed is transforming medical education with ‘flight simulators’ for surgeons. These simulators allow surgeons to train in a controlled, virtual environment and receive data-evidenced performance feedback. 

  1. Measure Selectively and Manage Expectations

With so much data, it’s tempting to ‘measure everything’. But this can be hugely counterproductive: it’s best to focus on actions and outcomes. Take these learnings from sport, for instance. Mo Wootten, a Sport Intelligence Analyst at UK Sports, discussed what they found from collecting sleep data. Not only was it not always useful to athletes, who already know if they don’t sleep as well before a major competition, but for some people it can be detrimental and a source of anxiety.

Jörg Corsten, Digital Medical Engagement Principal at Roche, warned against exaggerated expectations of AI and machine learning, reminding us that “we don’t have a general AI –nowhere we can just put in all the data and out comes the right answer.” Put another way, AI today resembles Siri – good at solving task-based problems – rather than HAL, the sentient AI from 2001: Space Odyssey.

  1. Acknowledge Your Bias

Our experiences and beliefs create unconscious biases, which, in turn, shape the way we see the world. We need to remain alert to potential bias in our datasets: metrics, tools and algorithms are created by people, so are vulnerable to the same foibles and biases that affect us.

Mo Wootten shared an example from the US criminal justice system, which integrates data models to predict the likelihood of re-offending. Tellingly, the algorithms used were shown to be racially biased.

The (big) data we have access to today can help us mitigate both problems: by triangulating from different data sources and perspectives – and consciously acknowledging our own cognitive biases – we can arrive at powerful insights.

  1. Blend Data and Storytelling – but Keep it Simple

Data-driven storytelling has the power to cut through information overload. Underpinning our stories with the right data creates relevance, but it is no easy feat. As Sam Knowles, Founder and Managing Director of Insight Agents, put it: “meaningfully bringing together the fire-and-ice worlds of storytelling, data and science is an art form.”

During the summit, Knowles shared his rules for compelling, data-driven storytelling as outlined in his book Narrative by Numbers. He highlighted that it is the combination of narrative skill and intelligent interrogation of data sources that creates real impact and, ultimately, influence.

So how do we do this? By keeping our story simple, being selective with our data and tapping into emotion.

  1. Get Ready for What’s Next

Digital data is increasingly fundamental to healthcare decision-making. In medical training, for instance, some European countries already embed digital performance data generated by virtual practical tests into certification and continuous education.

But not everyone is ready to embrace our data-rich environment. For some, the integration of real-world data helps to optimise healthcare (e.g. in disease registries) but others perceive it as challenging ‘clean’ (and controllable) clinical trial data.

Data privacy is not going to go away. Leaders in our field will be those who see the upside, rather than the challenge. There is an opportunity cost of doing nothing and falling behind.

Thinking this way, we may then find there are digital solutions already doing things that seem at first impossible, like reading facial expressions without compromising anonymity and data protection. This kind of solution already exists: it is used by the SBDB to conform with data privacy legislation while enabling ground-breaking, collaborative research at scale.

The 2019 Zurich Summit illustrated that it will take creativity and courage to make the most of our data-rich environment. It is when human brains and digital data connect to tell meaningful stories that strategy-changing insights can be unlocked. As one speaker noted, “data is a servant to decision-making, it should never be the master”.

Read More

Establishing health citizenship is critical for better health outcomes. So what how do we move forward to achieve this?

Jane Sarasohn-Kahn, Author, Health Economist & Advisor of THINK-Health joins the show to discuss key trends in health consumerism, health economics, and her latest book. Take a listen below.

Don’t miss an episode of What2Know, subscribe to our podcast on iTunesStitcher or Spotify!

If you’re interested in learning about W2O, check out our About and Healthcare page

Read More